A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with

Project: Research project

Project Details

StatusActive
Effective start/end date5/2/245/1/29

Funding

  • Sumitomo Pharma: $9,230.77